Literature DB >> 28318725

[Comparison of refraction with or without cycloplegia using Retinomax® or Plusoptix® devices].

E Bui Quoc1, S Guilmin Crepon2, S Tinguely3, G Lavallee3, G Busquet3, M Angot3, L Vera3.   

Abstract

PURPOSE: To evaluate the refraction in children measured with Plusoptix® without cycloplegia vs. Retinomax® apparatus with cycloplegia. PATIENTS AND METHODS: Measure of refraction with Plusoptix® in children>1year old referred for systematic vision screening, then measurement after cycloplegia with cyclopentolate by the Retinomax® device.
RESULTS: Thirty-three children were included, i.e. 66eyes. Mean age was 40.7months (minimum 12; maximum 114). The Spearman correlation coefficient for the spherical equivalent was 0.52 (Plusoptix® vs. Retinomax® comparison; P<0.0001=moderate correlation). The Spearman correlation coefficient was 0.73 for astigmatism (Plusoptix® vs. Retinomax® comparison; P<0.0001=strong correlation). The Plusoptix® sensitivity for measurement of refraction was 57%, 43% and 43% respectively for spherical equivalent, sphere and astigmatism. DISCUSSION AND
CONCLUSION: The correlation of astigmatism values is strong, whereas the correlation of sphere values is moderate. Plusoptix® seems to be unable to measure the exact refraction, because there is too large a dispersion of refraction measurements with Plusoptix®, compared to the exact refraction measured with the Retinomax®. Moreover, the sensitivity of Plusoptix® is low. Cycloplegic refraction remains indispensable in children.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Child; Cycloplegia; Cycloplégie; Enfant; Refraction; Réfraction

Mesh:

Year:  2017        PMID: 28318725     DOI: 10.1016/j.jfo.2016.10.012

Source DB:  PubMed          Journal:  J Fr Ophtalmol        ISSN: 0181-5512            Impact factor:   0.818


  1 in total

1.  Comparison of Adult Refractive Disorder Measurements Using HandyRef-K, Retinomax, Plusoptix, and Table-top Autorefractometer Devices.

Authors:  Zeynep Seymen; Sinan Bekmez; Erdem Eris; Burcin Kepez Yildiz; Asli Vural; Tulin Ogreden; Irfan Perente
Journal:  Beyoglu Eye J       Date:  2021-06-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.